A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients

PURPOSE: Combination therapy with aprepitant, serotonin receptor antagonist, and steroids improves the complete response rate of both acute and delayed chemotherapy-induced nausea and vomiting (CINV). However, it is not known whether ramosetron is suitable for administration in combination with apre...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Jang, Geundoo, Song, Hun Ho, Park, Keon Uk, Kim, Hyeong Su, Choi, Dae Ro, Kwon, Jung Hye, Kim, Ho Young, Han, Boram, Kim, Jung Han, Jung, Joo Young, Kim, Hyo Jung, Zang, Dae Young
פורמט: Artigo
שפה:Inglês
יצא לאור: Korean Cancer Association 2013
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804728/
https://ncbi.nlm.nih.gov/pubmed/24155675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.45.3.172
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים